A B S T R A C T The simultaneous administration of labeled human -G globulin and L-chains to subjects has allowed examination of the metabolic relationship between a component part and the whole immunoglobulin molecule. Studies were carried out in a series of control subjects and in a group of patients where substandard production of '-globulin was anticipated, i.e., patients with the nephrotic syndrome on chronic Imuran therapy and patients with uremia. Full expression of the plasma decay curve was obtained for both substances, that for L-chain requiring only 4-5 days except in uremic subjects and that for -y-globulin requiring up to 30-40 days. Urinary excretion of inorganic iodide was also quantitated for 20-30 days. Equilibrium of the extravascular, vascular, and urinary radioactivity from the labeled -yG globulin was usually not seen during this time interval suggesting more than one site of catabolism of the protein.
INTRODUCTION
Although the structure of the 'G globulins is well defined (1, 2) , factors governing the synthesis of the immunoglobulins are less well understood (3) . It seems likely that L-chains are produced in excess of their capability for use in synthesis of 'v-globulins in normal individuals, since they are found in measurable concentration in the blood and are known to undergo rapid degradation (4) . Heavy-chains are not normally found Dr. Abraham Received for publication 13 March 1972 and in revised form 20 December 1972. in blood and the possibility that these components are rate limiting in normal synthesis seems reasonable.
In states of suboptimal 'v-globulin synthesis several mechanisms for impaired production suggest themselves. First, less than normal amounts of either L-chains or heavy-chains or both might be produced. Second, production of these chains might be normal, but fabrication of the total molecule might be faulty. Insight into this problem was sought by the simultaneous study of L-chain and '-globulin production in a series of normal individuals and in two conditions where 'y-globulin synthesis is usually subnormal, i.e., the nephrotic syndrome and uremia. Although definitive answers to the above questions concerning impaired synthesis were not obtained, it seems likely that failure of L-chain production per se was not responsible for the reduced rate of 'v-globulin turnover in our abnormal subjects.
METHODS
Patient material and procedure. Five persons with renal disease and nine control subjects, three of whom were without disease, were chosen for study. As seen in Table I , minor chronic disease was present in six of the control subjects. Pertinent data concerning the patients with renal disease are also included in Table I . It is perhaps significant that despite proteinuria, neither patient with the nephrotic syndrome had measurable L-chain or 'yG globulin excretion. All patients with uremia excreted abnormal amounts of Lchain and one, J. Ga., had 'yG globulin proteinuria.
All were hospitalized on the Clinical Research Center and given 10 gtt Lugol solution daily, and on one occasion scanning over the thyroid gland was carried out which showed no uptake of radioactive iodine. Each was given approximately 25 ,uCi of 'I-labeled L-chains and 25 /ACi of 'I-labeled 'y-globulin by single intravenous injection. Blood samples were taken at 2, 3, 5, 10, 30, and 60 min and then at 4, 8, 12, 16 , and 24 h and usually daily thereafter for at least 20 days. Spot samples were collected thereafter for the time interval up to 40 days. Urines were collected continuously during the time of hospitalization and at intervals thereafter usually coinciding with the plasma samples. The IgG and L-chains were labeled as described by Bale, et al. (5) . Various preparations of the labeled proteins contained from 0.2 to 0.6 mol of radioiodine per mol of IgG or L-chain. 1 mg of protein contained a maximum of 50 ,uCi of specific activity. In order to remove any possibility of administering aggregated protein, all radiolabeled preparations were centrifuged at 35,000 rpm for 1 h in a Spinco model L preparative ultracentrifuge before injection. The top two-thirds of the centrifuged material was removed and utilized for injection. A sample from these preparations was precipitated in 5% trichloroacetic acid. In all cases greater than 99%o of the labeled protein was acid precipi- Qunantitation of scrum IgG and L-chain levels. Serum IgG levels were determined by radial immunodiffusion utilizing commercially available plates specific for IgG-Fc fragment (Meloy Laboratories, Springfield, Va.). All sera were assayed in triplicate at two dilutions of patient sera; levels were determined by comparison to the precipitin ring diameters obtained for various standards containing known concentrations of purified human JgG. Serum L-chain levels were determined by complement fixation utilizing two rabbit antisera, each specific for either K or X light-chain determinants. In order to obtain serum fractions free of contamination by intact immunoglobulins, 1 cm3 of the patient's serum was fractionated on a Sephadex G-100 column equilibrated with pH 7.4 phosphate-buffered saline ( Fig. 1 ). The column utilized had been previously calibrated with radiolabeled L-chain and IgG markers. The regions from the serum fractionation which corresponded in elution position to the L-chain markers were pooled and checked for lack of contamination by other immunoglobulins by immunodiffusion or complement fixation. These fractions were then tested via C' fixation for total quantity of Lchains present and the K-X ratios. All L-chain quantitations were performed at least twice. Further, in order to obtain precise quantitative data, determinations were performed within 1 wk after obtaining the L-chain serum pools.
Identification of the labeled suibstances in plasma and urine. In order to determine the catabolic products of the injected material, various serum and urine samples from each patient were placed on Sephadex G-100 columns. Further, precipitation of the protein-bound radiolabel in the urine and serum in 5%o trichloroacetic acid was performed on all samples. Samples of urine were placed on columns of ion exchange resins to determine if the recovered urine radioactivity was due to iodine bound to amino acids or to free iodine. In this manner it was determined that the intravascular radiolabeled protein remained intact during the period of the study and that the radiolabel in the urine existed as free iodine in normal individuals. These two parameters have not been previously checked.
Method of calculation. While all radioactivity given with labeled L-chain was recovered as inorganic urinary iodine, it became apparent early in the study that excreted inorganic iodide would not account for 100% of the injected dose of radioactivity given with yG globulin in the time interval of the study. It was also noted that the rate of urinary excretion of inorganic iodine over long time did not parallel the plasma radioactivity decay curve (Fig. 2) . Such observations led us to examine methods of calculation which would lead to valid interpretation. Exhaustive study of the interpretation of tracer protein curves has been done by Anderson (6), Nosslin (7), McFarlane and Jeejeebhoy (8) , Vitek (9) , and Mathews (10), which has been applied most extensively to iodinated albumin. In general, four analytical methods have been used with tracer data by various investigators to determine the amount of protein and its rate of turnover, i.e., (a) biological half-life as determined from the final decay rate, (b) metabolic clearance or fractional catabolic rate which estimates the fraction of the of 17.8±1.78 SEM. Other than the fact that the final disappearance is more rapid in the obese subjects there appears to be little that is unique for any group of subjects. The irreversible disposal rate (IDR) (Injected dose/f4x radioactivity per mass) which may be equated with production rate in these experiments is shown in Table II . In general, this value was positively correlated with the amount of intravascular globulin and our normal subjects (including obese) synthesized 35-62 mg/kg per day, with a mean of 47 mg/kg per day, a figure somewhat higher than usually quoted in the literature (11) .
Urinary excretion of inorganic iodine was obtained daily in all patients for at least 13 days and in three subjects for 30 days. All had periodic 24-h urine values determined after daily collections were discontinued so that we could extrapolate for total urinary excretion. In the control subjects where daily collections were made for 30 days, we had a total of 78, 75, and 54% of the injected dose excreted and final 24-h urines contained < 0.5% of the injected dose. Most subjects at this time interval had < 5% of the injected dose in the plasma, thus suggesting the possibility of sequestration of some is DAYS FIGURE 4 Plasma radioactivity disappearance curves of 'I-labeled -y-globulin of two very obese subjects, the two nephrotic subjects on Imuran, and the uremic patients. Shaded area represents data from six of the seven control subjects (P. Ra. excluded). The rapidity of the final disappearance rate in the obese patients is obvious. In general, the disappearance is slower than normal in the uremic subjects. of the labeled material outside the vascular compartment. Fig. 2 shows graphic representation of the data in subject B. Si. The amount of radioactivity remaining in the body, and the amount of radioactivity outside the vascular compartment showed a very slow decay, a consistent characteristic in nearly all subjects. Also the urinary radioactivity decreased faster than vascular, extravascular, or total body activity. These findings suggest at least two extravascular a-globulin pools, one of which exchanges very slowly with the vascular compartment. The changing metabolic clearance when referred to the plasma pool probably indicates more than one catabolic site for the injected protein.
Fractional catabolic rates as determined by urinary clearance from days 5-8 are listed in Table II (19) . L-chain metabolism. Labeled L-chains disappeared rapidly from the plasma in all subjects except those with uremia ( Figs. 5 and 6 ). Only 1-2% of the total radioactivity was present in the intravascular L-chain population at the end of 24 h and all injected radioactivity tabolism invariably resulted in temporary retention of cant radioactivity remained in the plasma L-chains for inorganic iodine in the blood. a week or more (see Fig. 6 ). As previously described (4, 20, 21) , the uremic sub-L-chain concentrations are shown in Table III and are jects had a slower decay curve for L-chains and signifi-quite variable even in the control population. Highest levels were seen in the uremic subjects while the lowest were seen in the patients with the nephrotic syndrome receiving Imuran (Burroughs Wellcome Co., Research Triangle Park, N. C.). Integration of these disappearance curves is less accurate than that for av-globulin because of the extremely rapid disappearance, but probably is accurate to +10%. Determination then of IDR or production rate shows values of 7.8-18.7 mg/kg per day of excess L-chains.
A positive correlation with blood concentration may be seen in all but the uremic subjects. Of considerable interest are the relatively normal synthetic rates in this latter group. Thus, the prolonged survival time of these low molecular weight proteins in uremic subjects, as noted previously (4), reflects only the increased pool size and carries no connotation for single molecules.
We mention in passing that all subjects had column separation (Sephadex G-100) of the urinary proteins Relationship Between L-Chain Synthesis and '-Globulin Production done. Neither individual with the nephrotic syndrome had any detectable L-chains in the urine. Those with uremia (P. Da., J. Ga., and M. Ra.) all had small amounts of L-chain in the urine (see Table I ).
DISCUSSION
Our data allow conclusions to be drawn concerning the relationship of excess L-chain and er-globulin metabolism
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C. Waterhouse, G. Abraham, and J. Vaughan only in normal subjects. We do not have sufficient data as to the effects of Imuran or uremia on this relationship and view our hypotheses in these areas as purely tentative until a larger series of subjects is available for study. It has been generally accepted that degradation of plasma proteins occurs intravascularly or at a rapidly equilibrating site (11) . The evidence for this is the apparent constant fractional catabolic rate as determined by urinary clearance over 3-14 days (6, 14) . Other investigators have noted a slow decline in this parameter with time in patients, (22, 23 ) and short-term early studies in rabbits have failed to show constancy (24) . Fur (14) . Conclusive evidence that no denaturation of the administered proteins has occurred during either isolation or labeling is difficult to obtain. We feel the following data make this an unlikely possibility. (a) Some protein preparations made by cold methanol or ethanol precipitation have been found to behave differently in vivo from proteins prepared with sodium sulfate (27, 28 Relationship Between L-Chain Synthesis and '-Globulin Production Similar findings have been noted by others (12) .
The decrease in fractional catabolic rate determined by urinary clearance which was seen in this study is as evident late in the study as it is during the initial days. It seems unlikely that denatured protein would still remain available for catabolism 2 wk after injection. We did not attain 100% excretion of the injected dose of labeled Y-globulin, in the time interval studied in any of our subjects. This finding is not unique for Y-globulin, but also has been reported for albumin, though to a lesser extent (29) . We made some attempt to determine the sites of the extravascular y-globulin and also to determine the mechanism of interchange between blood and the extravascular pool. It has been suggested that circulating a-globulin may become attached to specific leukocytes and thus leave the circulation intact (30) . A specific binding site of the Fc fragment may compete for attachment. Thus, the circulating white blood cells were isolated with dextran and counted. Also counts were made over the spleen and liver at various time intervals. Representative results of these limited studies are presented in Table IV . In general, significant counts were found on washed white cells in the four cases where these studies were done. At some time during the first 24 h after the tracer was given, radioactivity associated with the white cells was 5-10% of that found in 1 cm3 of plasma. Although the cells were isolated from 12-20 cm3 of plasma, no attempt at quantitation of leukocyte activity can be made since the completeness of the cell harvest is questionable. In no instance was radioactivity found on the white cells for more than 3 days. Also, in four cases, external counting over the precordium, spleen, liver, and thigh was done. In J. Ga (see Table IV ), splenectomy had been performed and the data on this patient served as a very rough control. At all time intervals studied in this patient, activity over the spleen area was less than that over the precordium. In all other subjects (e.g., G. Ab. in Table IV ), splenic activity exceeded precordial activity. We interpret these data to mean that early in the time-course of the experiments some radioactivity can be found on circulating leukocytes and that splenic sequestration, at least for short time intervals, is present. We do not feel that we have identified the site of prolonged extravascular storage which is seen in these subjects.
The possibility that the unexcreted radioactivity did not represent whole 'G globulin molecules, but sequestered inorganic iodine or partial degradation products of aG globulin was considered. Since none of the persons studied had any difficulty completely excreting inorganic iodide during the L-chain studies, only the possibility of partial degradation of aG needs consideration. This question is important in considering the possible biologic implications of the large retained extravascular pool, but the nature of our studies does not allow this distinction.
In our control subjects, an average of roughly 45% of the L-chains synthesized were not incorporated into av-globulin, but were discharged into the circulation and rapidly destroyed. In another recent study, X L-chain production has been estimated by administration of a labeled dimer (31) . Although plasma concentration of L-chain was not measured, indirect calculation was made from the fractional proteinuric rate and measured L-chain excretion. Their mean figure for circulating X L-chains was 0.93 mg/kg, while our mean for both X and K L-chains was 1.54 mg/kg. The comparable synthetic rates were 0.21 mg/kg per h vs. 0.54 mg/kg per h. In view of the fact that our studies used monemeric K and X L-chains and measured directly serum L-chain concentration (where the ratio of K-and X-chains may vary considerably), it seems to us that the resultant figures from the two studies are remarkably close. Both studies would seem to indicate the relatively inefficient use of L-chains in av-globulin synthesis.
In all patients with renal insufficiency and/or Imuran administration, low normal or diminished av-globulin synthesis was found. There was, in general, a parallel reduction in excess light-chain synthesis. Thus, the possibility exists that heavy-chain synthesis in some way regulates the synthesis of L-chains. Alternatively uremia may suppress independently and equally heavy and L-chain synthesis.
A final comment concerns the catabolism of L-chains. It is quite well established that destruction of L-chains normally occurs predominantly in the renal tissue after filtration and reabsorption. Our studies indicate that with renal disease, nearly normal production and catabolism can still occur but usually under the condition of a high concentration of L-chains (patients J. Ga. and M. Ra.). Since one of our patients, J. Ga., was studied before and after bilateral nephrectomy and showed almost identical degradation rates under the two circumstances, we confirm the finding that catabolism may occur at sites other than the kidney when renal disease is advanced (32) .
